88Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Egypt
Neuroscience Intelligence
Egypt neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #33 of 50 · Data maturity A · Research score 32.1 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
20Recruiting trials
31Publications
21Institutions
Executive interpretation
Egypt ranks #33 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Cairo University162 recruiting
Assiut University121 recruiting
Sohag University93 recruiting
Ain Shams University71 recruiting
Kafrelsheikh University73 recruiting
October 6 University50 recruiting
Tanta University42 recruiting
Sherief Abd-Elsalam33 recruiting
Mansoura University Hospital30 recruiting
Mansoura University20 recruiting
Disease activity
Stroke14trials
Epilepsy14trials
Other Neurology11trials
Pain Neuropathy8trials
Multiple Sclerosis7trials
Autism6trials
Other Psychiatry4trials
Depression4trials
Anxiety4trials
Adhd3trials
Research institutions
Military Medical AcademyOpenAlexlinked institution
Ain Shams University HospitalOpenAlexlinked institution
Egyptian Society of CardiologyOpenAlexlinked institution
Kafrelsheikh UniversityOpenAlexlinked institution
Assiut UniversityOpenAlexlinked institution
Suez Canal UniversityOpenAlexlinked institution
Damanhour UniversityOpenAlexlinked institution
Al-Azhar UniversityOpenAlexlinked institution
Benha UniversityOpenAlexlinked institution
Alexandria UniversityOpenAlexlinked institution
Clinical evidence trail
NCT07790432Parental Stress and Its Relationship With Perceived Social Support and Screen Time Among Caregivers of Children With Attention-Deficit/Hyperactivity DisorderNOT_YET_RECRUITING
NCT07762040Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisNOT_YET_RECRUITING
NCT07338682Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric PatientsRECRUITING
NCT07147582Effect of Transcranial Alternating Current Stimulation on Sleep Disorder and Anxiety in Elderly PopulationNOT_YET_RECRUITING
NCT06980298Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric DisordersNOT_YET_RECRUITING
NCT06813599The Best Intervention to Improve Gait Pattern in Children with Spastic Diplegic Cerebral PalsyNOT_YET_RECRUITING
NCT06803095Efficacy of Walking Exercise With Dog on Tinnitus Complaints in Sleep Apnea (Obstructive Sleep Apnea)RECRUITING
Research evidence trail
PUBMEDThe Arabic Generalized Anxiety Disorder 2 (GAD-2): Psychometric evaluation among mothers of children with intellectual disabilities.2026-12-01
PUBMEDBetaine Attenuates Cuprizone-Induced Cortical Demyelination: The Role of the WNT4/mTOR Signalling Pathway in Regulating Astrogliosis and Synaptic Integrity.2026-11-01
PUBMEDOne target, two evidence streams: Rituximab versus ocrelizumab in relapsing multiple sclerosis: A design-stratified systematic review, meta-analysis, and concordance assessment.2026-11-01
PUBMEDLate-onset versus adult-onset multiple sclerosis: A comparative analysis of clinical, radiological, and confirmed disability progression.2026-11-01
PUBMEDFrom theory to practice: physicians' knowledge, attitudes, and practices regarding amyotrophic lateral sclerosis in Egypt - a cross-sectional study.2026-11-01
PUBMEDChallenging historical associations and reassuring women: an updated meta-analysis of multiple sclerosis relapse risk following assisted reproductive technology.2026-11-01
PUBMEDRestless legs syndrome and other neurological disorders: A systematic-narrative hybrid literature review with exploratory meta-analysis.2026-10-17
PUBMEDShort term effect of repetitive transcranial magnetic stimulation of the medial sensorimotor cortex for neurogenic pelvic floor dysfunction in multiple sclerosis: a randomized, double blind, sham controlled trial.2026-10-17
PUBMEDProtective effects of Matricaria chamomilla L. extract against PTZ-induced epilepsy: Targeting neuroinflammations, glial reactivity and neurofilaments.2026-10-12
PUBMEDToward regionally equitable precision medicine: microbiota‑associated mechanisms and emerging personalized strategies in multiple sclerosis.2026-10-08
PUBMEDPatients with hemispheric epilepsy: Electroclinical characteristics and factors associated with intractability.2026-10-07
PUBMEDPercutaneous balloon compression followed by perineural methylprednisolone for trigeminal neuralgia: A 50-patient retrospective series with 12-month outcomes.2026-10-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.